In addition to these studies on Roneparstat, another heparanase inhibitor, PG545, was recently shown to enhance the anticancer activity of chemotherapies in animal models of ovarian and pancreatic cancer [19, 20]. Here, HPSE is linked to familial pancreatic carcinoma.